Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
In Re: Pradaxa (Dabigatran Etexilate) Products Liability Litigation
Case Number:
3:12-md-02385
Court:
Nature of Suit:
Multi Party Litigation:
Multi-district Litigation
Judge:
Firms
- Burg Simpson
- Butler Snow LLP
- Covington & Burling
- Douglas & London
- Lowey Dannenberg
- Niemeyer Grebel
- Schlichter Bogard
- Sills Cummis
- TorHoerman Law
Companies
- Aetna Inc.
- AvMed Inc.
- Blue Cross Blue Shield Association
- Boehringer Ingelheim
- Boehringer Ingelheim Vetmedica Inc.
- Centene Corp.
- Florida Blue
- Government Employees Health Association Inc.
- Group Health Cooperative
- Humana Inc.
- Premera Blue Cross
- WellCare Health Plans Inc.
Sectors & Industries:
-
May 28, 2014
Boehringer Pays $650M To Settle Pradaxa MDL
Boehringer Ingelheim International GmbH has agreed to pay roughly $650 million to settle claims in multidistrict litigation that its blood thinner Pradaxa caused serious injuries including severe bleeding, the German drugmaker said Wednesday.
-
March 13, 2014
Boehringer Hit With New Sanctions In Pradaxa MDL
An Illinois federal judge ordered Boehringer Ingelheim International GmbH on Thursday to reimburse plaintiffs for the offices they rent for European depositions in the multidistrict litigation over the blood thinner Pradaxa, a discovery-related sanction on top of last year's nearly $1 million fine.
-
February 13, 2014
Boehringer Faces 2,000-Plus Pradaxa Injury Suits
Just 18 months after a multidistrict litigation was formed, Boehringer Ingelheim International GmbH is now facing more than 2,000 lawsuits in the U.S. over severe bleeding and other injuries allegedly caused by its blood thinner Pradaxa, the drugmaker said Thursday.
-
January 30, 2014
Boehringer Docs In Pradaxa MDL Unsealed By Judge
An Illinois federal judge on Wednesday unsealed dozens of documents in the multidistrict litigation over Boehringer Ingelheim International GmbH's blood thinner Pradaxa, finding the German drugmaker had not sufficiently explained why it had marked them as confidential.
-
January 03, 2014
7th Circ. Blocks Boehringer Workers' Depos In Pradaxa MDL
The Seventh Circuit on Thursday temporarily blocked Germany-based Boehringer Ingelheim International GmbH employees from being deposed in the U.S. in personal injury multidistrict litigation over the blood thinner Pradaxa, after the drugmaker argued a lower court overstepped its authority.
-
December 19, 2013
Boehringer May Face More Sanctions In Pradaxa MDL
A week after hitting Boehringer Ingelheim International GmbH with a nearly $1 million penalty for discovery abuses, an Illinois federal judge ruled Wednesday that the drugmaker may be slapped with even more sanctions in multidistrict litigation over its blood thinner Pradaxa.
-
December 09, 2013
Boehringer Fined $1M For Withholding Docs In MDL
An Illinois federal judge on Monday slapped Boehringer Ingelheim Pharmaceuticals Inc. with nearly $1 million in sanctions for discovery abuses in multidistrict litigation over its oral anticoagulant Pradaxa, finding that the drugmaker's failure to produce thousands of documents amounted to bad-faith conduct.